| mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.2 |
6e-05 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.4 |
7e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
8e-05 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-05 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |